HIMS vs LIFE vs ELV Stock Comparison

Hims & Hers Health, Ethos Technologies and Elevance Health Prices as of Nov 16, 2026 Peers: Industry group
ELV Elevance Health, Inc.
$446.47 +4.3% 1M +37.0% 1Y
Market cap
$93.96B
P/E
18.3x
Revenue (TTM)
$201.83B
Div. yield
–
Managed Care Healthcare
5 wins

Head to Head

7 decided of 12

Elevance Health leads on 5 of the 12 questions below (Elevance Health 5, Hims & Hers Health 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionHIMSLIFEELVLeader
Larger companyMarket capitalisation $4.13B $2.11B $93.96B ELV
Cheaper on earningsLower P/E, profitable companies only -21.7x -17.1x 18.3x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — 14.3x –
Faster revenue growthRevenue growth, trailing twelve months +29.8% — +3.6% HIMS
More profitableNet margin, trailing twelve months -6.6% -16.9% 2.5% ELV
Better return on capitalReturn on invested capital — — 8.3% –
Less leveragedLower net debt / EBITDA — — -0.5x –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -49.8% — +37.0% ELV
Better 5-year returnAnnualised price return, 5 years +18.0%/yr — +0.8%/yr HIMS
Less volatileAnnualised volatility, 1 year 91.2% 89.1% 35.8% ELV
Higher overall scoreMean of the five percentile scores vs peers 38/100 39/100 68/100 ELV

Percentile Scorecard

HIMSLIFEELV

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHIMSLIFEELV
Valuation 36 #64 of 99 43 #57 of 99 81 #6 of 27
Growth 24 #68 of 89 – 36 #17 of 26
Profitability 33 #62 of 92 42 #54 of 92 72 #8 of 26
Financial Health 20 #83 of 103 62 #40 of 103 68 #9 of 26
Shareholder Returns 76 #16 of 63 10 #57 of 63 82 #4 of 18
Overall 38 39 68
  • HIMS ranked among 103 companies in Healthcare Providers
  • LIFE ranked among 103 companies in Healthcare Providers
  • ELV ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHIMSLIFEELVSPY
1 month -33.9%-9.4%+4.3% -3.0%
3 months -35.2%-3.4%+14.4% -4.2%
6 months -16.7%+64.0%+13.3% +0.2%
Year to date -42.8%—+27.4% +8.5%
1 year -49.8%—+37.0% +10.1%
3 years +148.5%—-3.6% +64.1%
3 years, per year +35.5%—-1.2% +18.0%
5 years +128.6%—+3.9% +58.1%
5 years, per year +18.0%—+0.8% +9.6%
10 years ——+222.6% +239.6%
10 years, per year ——+12.4% +13.0%

Risk

MeasureHIMSLIFEELVSPY
Volatility, 1Y 91.2%89.1%35.8% 13.8%
Downside volatility, 1Y 86.9%85.8%38.2% 14.2%
Beta vs S&P 500, 1Y 2.591.820.25 1.00
Return / volatility, 1Y -0.55—1.03 0.74
Max drawdown, 5Y -78.9%-50.1%-51.2% -25.4%
From 52-week high -53.6%-23.1%0.0% -5.0%
52-week high $40.02$44.22$446.47 $779.14
52-week low $14.52$9.85$280.74 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHIMSLIFEELV
P/E now vs peer median -24.2xmedian 22.4x -17.4xmedian 22.4x 18.1xmedian 25.2x
P/S now vs peer median 1.6xmedian 1.3x 3.0xmedian 1.3x 0.5xmedian 0.4x
EV/EBITDA now vs peer median -33.4xmedian 14.2x -17.9xmedian 14.2x 9.6xmedian 14.5x
P/FCF now vs peer median 145.7xmedian 19.0x 19.5xmedian 19.0x 14.3xmedian 16.5x
P/B now vs peer median 13.0xmedian 2.6x 4.2xmedian 2.6x 2.1xmedian 2.7x
PEG now vs peer median 0.35median 0.84 —median 0.84 -7.75median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHIMSLIFEELV
Revenue $2.87B $727.95M $201.83B
Gross profit $1.83B $714.19M $53.35B
Operating income -$232.48M -$116.88M $7.70B
Net income -$190.81M -$117.63M $5.13B
Free cash flow $31.68M $110.81M $6.51B
R&D $212.19M – –
EPS (diluted) $-0.82 $-1.78 $23.62
Cash & equivalents $605.60M $149.80M $10.35B
Total debt – – $30.76B
Shares (diluted) 233.82M 69.21M 217.60M
Enterprise value $1.25B $1.45B -$48.62B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHIMSLIFEELV
P/E -24.2x -17.4x 18.1x
P/FCF 145.7x 19.5x 14.3x
P/Operating cash flow 25.6x 19.2x 12.2x
P/S 1.6x 3.0x 0.5x
P/B 13.0x 4.2x 2.1x
P/Tangible book -110.0x 4.2x 2.7x
EV/EBITDA -33.4x -17.9x 9.6x
EV/EBIT -16.8x -16.6x 11.4x
EV/Revenue 1.4x 2.7x 0.4x
EV/FCF 123.2x 17.5x 13.5x
EV/Operating cash flow 21.7x 17.2x 11.6x
PEG (3Y EPS CAGR) 0.35 – -7.75

Growth

14 metrics
MetricHIMSLIFEELV
Revenue growth (1Y) 29.8% – 3.6%
Revenue CAGR (3Y) 53.6% – 6.2%
Gross profit growth (1Y) 10.4% – 4.3%
Gross profit CAGR (3Y) 41.7% – 5.5%
Operating income growth (1Y) -302.1% – -9.2%
Operating income CAGR (3Y) -78.8% – -4.2%
Net income growth (1Y) -242.6% – -7.4%
Net income CAGR (3Y) -74.8% – -5.2%
EPS growth (1Y) -251.7% – -4.5%
EPS CAGR (3Y) -68.7% – -2.3%
Operating cash flow growth (1Y) -44.6% – 54.6%
Operating cash flow CAGR (3Y) 59.0% – -7.2%
Free cash flow growth (1Y) -76.3% – 72.9%
Free cash flow CAGR (3Y) -3.1% – -7.6%

Profitability

14 metrics
MetricHIMSLIFEELV
Gross margin 63.8% 98.1% 26.4%
EBITDA margin -4.1% -14.9% 4.6%
Operating margin -8.1% -16.1% 3.8%
Pretax margin -7.7% -15.5% 3.1%
Net margin -6.6% -16.9% 2.5%
FCF margin 1.1% 15.2% 3.2%
Operating cash flow margin 6.3% 15.5% 3.8%
Return on equity -65.9% -23.8% 11.4%
Return on assets -6.2% -15.6% 4.0%
Return on invested capital – – 8.3%
Return on capital employed -10.8% -24.6% 9.6%
Asset turnover 0.8x 1.0x 1.6x
Cash conversion (OCF / net income) -0.9x -1.0x 1.5x
Stock comp / revenue 6.2% 32.6% 0.1%

Financial Health

11 metrics
MetricHIMSLIFEELV
Debt / assets – – 24.1%
Debt / equity – – 0.7x
Net debt / EBITDA – – -0.5x
Debt / FCF – – 4.7x
Liabilities / assets 90.0% 36.7% 65.0%
Equity / assets 10.0% 63.3% 35.0%
Interest coverage – -48.7x 5.3x
Current ratio 0.9x 1.5x 1.5x
Quick ratio 0.8x 1.1x 1.2x
Cash ratio 0.5x 0.8x 0.8x
Altman Z-score 1.29 4.57 3.06

Shareholder Returns

7 metrics
MetricHIMSLIFEELV
Dividend yield – – 1.6%
Net buyback yield 1.3% -4.6% 2.2%
Shareholder yield 1.3% -4.6% 3.8%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHIMSLIFEELV
Forward P/E – – 14.3xFY2026
EPS, next fiscal year $-0.93FY2026 $-2.33FY2026 $30.12FY2026
EPS growth, next FY -282.4%FY2026 -291.0%FY2026 -0.6%FY2026
EPS growth, the year after – – +4.2%
Revenue, next fiscal year $3.28BFY2026 $867.88MFY2026 $211.92BFY2026
Revenue growth, next FY +39.8%FY2026 +123.9%FY2026 +7.3%FY2026
Revenue growth, the year after +25.4% +31.4% +0.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersHIMSLIFEELV
Held by institutions 69.3% 27.7% 91.8%
Institutions holding 510 72 1,615
Change in shares held, QoQ +4.4% -3.8% +1.7%
Institutions buying 325 37 862
Institutions selling 130 20 542
Buyers to sellers 2.50 1.85 1.59

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

HIMSLIFEELV
HIMS 1.00 0.20 0.01
LIFE 0.20 1.00 0.05
ELV 0.01 0.05 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, HIMS, LIFE and ELV?

Elevance Health (ELV) is the largest by market capitalisation: Hims & Hers Health (HIMS) $4.13B, Ethos Technologies (LIFE) $2.11B, Elevance Health (ELV) $93.96B.

Which company is growing faster?

Hims & Hers Health (HIMS) grew revenue fastest over the trailing twelve months: Hims & Hers Health (HIMS) +29.8%, Elevance Health (ELV) +3.6%.

Which company is more profitable?

Elevance Health (ELV) has the highest net margin (Hims & Hers Health (HIMS) -6.6%, Ethos Technologies (LIFE) -16.9%, Elevance Health (ELV) 2.5%).

Which stock has performed better?

Over the past year Elevance Health (ELV) returned the most: Hims & Hers Health (HIMS) -49.8%, Elevance Health (ELV) +37.0%. Over five years, Hims & Hers Health (HIMS) compounded fastest (Hims & Hers Health (HIMS) +18.0%/yr, Elevance Health (ELV) +0.8%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Elevance Health (ELV) has been the steadiest (Hims & Hers Health (HIMS) 91.2%, Ethos Technologies (LIFE) 89.1%, Elevance Health (ELV) 35.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, HIMS, LIFE and ELV?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Elevance Health (ELV) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.